 Cytochrome P-450 CYP3A Inducers
"Cytochrome P-450 CYP3A Inducers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A.
| Descriptor ID |
D065701
|
| MeSH Number(s) |
D27.505.389.249.700 D27.505.519.349.700
|
| Concept/Terms |
Cytochrome P-450 CYP3A Inducers- Cytochrome P-450 CYP3A Inducers
- Cytochrome P 450 CYP3A Inducers
- P450 CYP3A Inducers
- Inducers, P450 CYP3A
- CYP3A Inducers
- Inducers, CYP3A
Cytochrome P-450 CYP3A5 Inducers- Cytochrome P-450 CYP3A5 Inducers
- Cytochrome P 450 CYP3A5 Inducers
- P450 CYP3A5 Inducers
- Inducers, P450 CYP3A5
- CYP3A5 Inducers
- Inducers, CYP3A5
Cytochrome P-450 CYP3A7 Inducers- Cytochrome P-450 CYP3A7 Inducers
- Cytochrome P 450 CYP3A7 Inducers
- P450 CYP3A7 Inducers
- Inducers, P450 CYP3A7
- CYP3A7 Inducers
- Inducers, CYP3A7
Cytochrome P-450 CYP3A4 Inducers- Cytochrome P-450 CYP3A4 Inducers
- Cytochrome P 450 CYP3A4 Inducers
- P450 CYP3A4 Inducers
- CYP3A4 Inducers, P450
- Inducers, P450 CYP3A4
- CYP3A4 Inducers
- Inducers, CYP3A4
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP3A Inducers".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP3A Inducers".
This graph shows the total number of publications written about "Cytochrome P-450 CYP3A Inducers" by people in this website by year, and whether "Cytochrome P-450 CYP3A Inducers" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytochrome P-450 CYP3A Inducers" by people in Profiles.
-
Lazorwitz A, Sheeder J, Teal S. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study. Contraception. 2023 07; 123:110035.
-
Francis J, Mngqibisa R, McIlleron H, Kendall MA, Wu X, Dooley KE, Firnhaber C, Godfrey C, Cohn SE, Denti P. A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment. Clin Pharmacol Ther. 2021 10; 110(4):1057-1065.
-
Ramsden D, Fung C, Hariparsad N, Kenny JR, Mohutsky M, Parrott NJ, Robertson S, Tweedie DJ. Perspectives from the Innovation and Quality Consortium Induction Working Group on Factors Impacting Clinical Drug-Drug Interactions Resulting from Induction: Focus on Cytochrome 3A Substrates. Drug Metab Dispos. 2019 10; 47(10):1206-1221.
-
Lazorwitz A, Davis A, Swartz M, Guiahi M. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users. Contraception. 2017 Jun; 95(6):571-577.
-
Donaldson SH, Solomon GM, Zeitlin PL, Flume PA, Casey A, McCoy K, Zemanick ET, Mandagere A, Troha JM, Shoemaker SA, Chmiel JF, Taylor-Cousar JL. Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. J Cyst Fibros. 2017 May; 16(3):371-379.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|